{
    "status": "ok",
    "totalResults": 10,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Haemonetics : to Acquire OpSens, Inc. Presentation",
            "description": "(marketscreener.com) \n \n \n Haemonetics Corporation Announces\n \n \n Definitive Agreement to Acquire OpSens, Inc.\n \n \n October 10, 2023\n \n \n \n \n \u00a9 2023 Haemonetics Corporation\n \n \n \n \n \n \n IMPORTANT INFORMATION\n \n \n...https://www.marketscreener.com/quote/stock/H\u2026",
            "url": "https://www.marketscreener.com/quote/stock/HAEMONETICS-CORPORATION-12870/news/Haemonetics-to-Acquire-OpSens-Inc-Presentation-45027469/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-10T10:20:02Z",
            "content": "IMPORTANT INFORMATION\r\nSafe Harbor for Forward-Looking Statements\r\nThis presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21\u2026 [+5292 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.",
            "description": "(marketscreener.com) \n\nExpands Haemonetics' Hospital portfolio with innovative fiber optic sensor technology for interventional cardiology\nSignificant commercial synergies with Haemonetics' existing Vascular Closure portfolio \nAccelerates Haemonetics' transfo\u2026",
            "url": "https://www.marketscreener.com/quote/stock/OPSENS-INC-120793678/news/Haemonetics-Corporation-Announces-Definitive-Agreement-to-Acquire-OpSens-Inc-45027240/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-10T10:01:06Z",
            "content": "Expands Haemonetics' Hospital portfolio with innovative fiber optic sensor technology for interventional cardiology\r\nSignificant commercial synergies with Haemonetics' existing Vascular Closure portf\u2026 [+13429 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023",
            "description": "(marketscreener.com) \n\nBOSTON, Oct. 5, 2023 /PRNewswire/ -- Haemonetics Corporation announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, November 2, 2023. The Company will hold a conference\u2026",
            "url": "https://www.marketscreener.com/quote/stock/HAEMONETICS-CORPORATION-12870/news/Haemonetics-Sets-Date-for-Publishing-Second-Quarter-Fiscal-Year-2024-Results-November-2-2023-44995615/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-05T20:06:10Z",
            "content": "BOSTON, Oct. 5, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, Nov\u2026 [+2492 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Investing.com"
            },
            "author": "Investing.com",
            "title": "Citigroup Maintains Neutral Outlook on Haemonetics With a Target Price Set at $108.85",
            "description": "Citigroup Maintains Neutral Outlook on Haemonetics With a Target Price Set at $108.85",
            "url": "https://www.investing.com/news/stock-market-news/citigroup-maintains-neutral-outlook-on-haemonetics-with-a-target-price-set-at-10885-93CH-3189529",
            "urlToImage": "https://i-invdn-com.investing.com/news/LYNXMPEE0N1V4_L.jpg",
            "publishedAt": "2023-10-03T18:18:13Z",
            "content": "Citigroup (NYSE:C) has maintained its neutral stance on Haemonetics Corporation (NYSE:NYSE:HAE), a global healthcare solutions provider, forecasting a one-year target price of $108.85, marking a 23.4\u2026 [+2046 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "FMC Corporation names Jacqueline Scanlan as new chief human resources officer",
            "description": "(marketscreener.com) \n\n\u00a0\n\nPHILADELPHIA, Sept. 25, 2023\u00a0 /PRNewswire/ -- FMC Corporation announced today that Jacqueline Scanlan has been named executive vice president and\u00a0chief human resources officer .\u00a0Scanlan will lead the global Human Resources function a\u2026",
            "url": "https://www.marketscreener.com/quote/stock/FMC-CORPORATION-12616/news/FMC-Corporation-names-Jacqueline-Scanlan-as-new-chief-human-resources-officer-44914369/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-25T11:31:05Z",
            "content": "PHILADELPHIA, Sept. 25, 2023\u00a0 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today that Jacqueline (Jackie) Scanlan has been named executive vice president and\u00a0chief human resources officer (C\u2026 [+3967 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Leukapheresis Market Research Report 2023 - Global Opportunity/Analysis to 2028",
            "description": "Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The \"Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Ph\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748799/28124/en/Leukapheresis-Market-Research-Report-2023-Global-Opportunity-Analysis-to-2028.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-25T14:33:00Z",
            "content": "Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The \"Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), \u2026 [+7686 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023",
            "description": "BOSTON, Oct. 5, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, November 2, 2023. The Company will hold a conference call with \u2026",
            "url": "https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2024-results-november-2-2023-301948865.html",
            "urlToImage": "https://mma.prnewswire.com/media/351568/Haemonetics_Corporation_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-05T20:05:00Z",
            "content": "BOSTON, Oct. 5, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, Nov\u2026 [+2265 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Brainy Insights Pvt. Ltd.",
            "title": "Apheresis Equipment Market Size to Reach USD 8.51 Billion by 2032, Says The Brainy Insights",
            "description": "Latest report published by The Brainy Insights provides analysis on apheresis equipment market size during 2023-2032. The global apheresis equipment market was valued at USD 3.0 billion in 2022 and is expected to reach USD 8.51 billion by 2032. North America \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/13/2742687/0/en/Apheresis-Equipment-Market-Size-to-Reach-USD-8-51-Billion-by-2032-Says-The-Brainy-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e0ed2f75-5061-4c4a-a30b-65427e5cc0f4",
            "publishedAt": "2023-09-13T15:00:00Z",
            "content": "Newark, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 3.0 billion\u00a0apheresis equipment market will reach USD 8.51 billion by 2032. The increasing prevalence of chronic \u2026 [+7315 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "FMC Corporation names Jacqueline Scanlan as new chief human resources officer",
            "description": "PHILADELPHIA, Sept. 25, 2023 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today that Jacqueline (Jackie) Scanlan has been named executive vice president and chief human resources officer (CHRO). Scanlan will lead the global Human Resources (HR) funct\u2026",
            "url": "https://www.prnewswire.com/news-releases/fmc-corporation-names-jacqueline-scanlan-as-new-chief-human-resources-officer-301936469.html",
            "urlToImage": "https://mma.prnewswire.com/media/2218735/JScanlan.jpg?p=facebook",
            "publishedAt": "2023-09-25T11:30:00Z",
            "content": "PHILADELPHIA, Sept. 25, 2023\u00a0 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today that Jacqueline (Jackie) Scanlan has been named executive vice president and\u00a0chief human resources officer (C\u2026 [+3786 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Global Leukapheresis Market Research Report 2023: A Combined Leukopaks and Leukapheresis $1.2 Billion Market by 2028 - Opportunities in Increasing Investments in Car-T Therapies in Emerging Economies",
            "description": "DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The \"Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma\u2026",
            "url": "https://www.prnewswire.com/news-releases/global-leukapheresis-market-research-report-2023-a-combined-leukopaks-and-leukapheresis-1-2-billion-market-by-2028---opportunities-in-increasing-investments-in-car-t-therapies-in-emerging-economies-301936149.html",
            "urlToImage": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-23T01:30:00Z",
            "content": "DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The \"Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Appl\u2026 [+8078 chars]"
        }
    ]
}